MedCity News
JUNE 23, 2024
Telehealth advocates are calling on Congress to act quickly on Medicare telehealth flexibilities, which are set to expire at the end of the year. Doing so would help key healthcare stakeholders prepare. The post Medicare Telehealth Flexibilities Will Expire In December. Congress Needs To Act Swiftly, Experts Say appeared first on MedCity News.
pharmaphorum
JUNE 23, 2024
Netherlands biotech Argenx has a second FDA approval for its FcRn inhibitor Vyvgart Hytrulo, adding a new indication in chronic inflammatory demyelinating polyneuropathy (CIDP) for a drug that it hopes could find a use in more than a dozen diseases.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
JUNE 23, 2024
Ascidian Therapeutics’ technology edits RNA to treat inherited disorders. While the startup’s lead internal program is for the retinal disorder Stargardt disease, its new R&D alliance with Roche will focus on developing RNA-editing therapies for neurological indications. The post Roche Adds Another Neuro Alliance, Inking R&D Pact With RNA-Editing Startup Ascidian appeared first on MedCity News.
pharmaphorum
JUNE 23, 2024
Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 were able to come off insulin within a year
MedCity News
JUNE 23, 2024
Leveraging technology as a force multiplier can significantly help nursing programs graduate more practice-ready nurses to care for patients in their communities. The post Embracing Technology in Nursing Education to Grow the Nursing Pipeline appeared first on MedCity News.
PharmaTech
JUNE 23, 2024
See how Supor Prime filters performed against two comparable products in filtering fluids with antibody concentrations of 70 g/L to 220 g/L. And be sure to request a sample!
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Pharmacy Times
JUNE 23, 2024
Food is medicine is a framework of policy and behavioral interventions, improving population health through access to healthy foods to increase food and nutrition security.
MedCity News
JUNE 23, 2024
NeuroFlow acquired Owl, a provider of measurement-based behavioral health care. These types of consolidations will drive the future of behavioral health care, according to NeuroFlow CEO Chris Molaro. The post NeuroFlow Acquires 2nd Behavioral Health Company in 1 Year appeared first on MedCity News.
Pharmacy Times
JUNE 23, 2024
Jennifer Goldman discusses the importance of collaborative care between providers like endocrinologists, cardiologists, primary care physicians, and pharmacists to manage diabetes and prevent cardiovascular events.
Pharmacy Times
JUNE 23, 2024
W. Timothy Garvey expressed concern over limited access to effective obesity medications like Ozempic due to shortages and high costs, urging stakeholders to work together on developing solutions.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharmacy Times
JUNE 23, 2024
Potential concerns surrounding GLP-include pancreatitis, pancreatic cancer, colorectal cancer, suicide and other phycological effects, and thyroid cancer.
Pharmacy Times
JUNE 23, 2024
Niki Shah Vice President of Impact Innovation and Activation at McKesson, discusses efforts to advance health equity and access through community pharmacy initiatives.
Pharmacy Times
JUNE 23, 2024
Adding a community health worker can improve the overall health equity for your patients.
Pharmacy Times
JUNE 23, 2024
Semaglutide significantly improved heart failure symptoms and quality of life through weight loss and direct effects on heart tissue.
Expert insights. Personalized for you.
122 
Let's personalize your content